imatinib mesylate has been researched along with 1-(4-(3-bromophenoxy)butyl)-1h-imidazole in 1 studies
Studies (imatinib mesylate) | Trials (imatinib mesylate) | Recent Studies (post-2010) (imatinib mesylate) | Studies (1-(4-(3-bromophenoxy)butyl)-1h-imidazole) | Trials (1-(4-(3-bromophenoxy)butyl)-1h-imidazole) | Recent Studies (post-2010) (1-(4-(3-bromophenoxy)butyl)-1h-imidazole) |
---|---|---|---|---|---|
11,477 | 960 | 5,773 | 6 | 0 | 5 |
Protein | Taxonomy | imatinib mesylate (IC50) | 1-(4-(3-bromophenoxy)butyl)-1h-imidazole (IC50) |
---|---|---|---|
Heme oxygenase 2 | Rattus norvegicus (Norway rat) | 2.2 | |
Heme oxygenase 2 | Homo sapiens (human) | 2.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acquaviva, R; Barbagallo, I; Di Giacomo, C; Modica, MN; PittalĂ , V; Romeo, G; Salerno, L; Siracusa, MA; Sorrenti, V; Tibullo, D | 1 |
1 other study(ies) available for imatinib mesylate and 1-(4-(3-bromophenoxy)butyl)-1h-imidazole
Article | Year |
---|---|
Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.
Topics: Animals; Antineoplastic Agents; Brain; Cell Cycle Checkpoints; Cell Line; Cell Survival; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Imidazoles; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spleen; Triazoles | 2013 |